In silico screening, synthesis and in vitro evaluation of some quinazolinone and pyridine derivatives as dihydrofolate reductase inhibitors for anticancer activity

E-Journal of Chemistry

Volumn 6, Issue SUPPL. 1, 2009, Pages

  Nerkar, A G ^a   Saxena, A K ^b   Ghone, S A ^a   Thaker, A K ^a  

^a Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Anticancer activity; DHF.R.; Docking and pyridines.; In silico screening.; Quinazolinones.; Schiff's bases.

Indexed keywords

EID: 79953073824     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2009/506576     Document Type: Article

References (13)

1. Chakraborty A K and Thilagavathi R, Internet Electron. J Mol Des., 2004, 3(11), 704.
2. Gangjee A, Zeng Y, Ihnat M, Warnke L A, Green D W, Kisliuk R L and Lin F T, Bioorg Med Chem., 2005, 13, 5475.
3. Axe F U, Scott D B and Zalma S S, J Mol Graph Model, 2006, 24, 456.
4. Silva da C H T P, Campo V L, Carvalho I and Taft C A, J Mol Graph Model, 2006, 25,169.
5. Deng Q , Lu Z , Bohn J , Ellsworth K P, Myers R W , Geissler W M , Harris G, Willoughby C A, Chapman K, Mckeever B and Mosley R, J Mol Graph Model, 2005, 23, 457.
6. Gschwend D A, Sirawaraporn W, Santi D V and Kuntz I D, Science, 1998, 259, 1445.
7. Teijido M V, Caracelli I and Zukerman-Schpector J, J Mol Graph Model, 2006, 24, 349.
8. Martic M, Tatic I, Markovic S, Kujundzic N and Kostrun S, Eur J Med Chem., 2004, 39, 141.
9. Roth B, Fed Proc., 1986, 45, 2765.
10. Jolivet J, Cowan K H, Curt G A, Clendeninn N J and Chabner B A, N Eng J Med., 1983, 309, 75.
11. Argyou A, Blanchard J S, Wetting M W and Aladeqbami B, Nat Struct Mol Biol., 2006, 13(5), 408.
12. Srivastava V, Kumar A, Mishra B N and Siddiqui M I, Bioinformation, 2008, 3(4), 180.
13. Yamini L and Vijjulatha M, E Journal of Chemistry, 2008, 5(2), 263,